✦ LIBER ✦

Phase III study of liposome-encapsulated doxorubicin (TLC D-99) and cyclophosphamide (CPA) vs. epirubicin (EPI) and CPA in first-line treatment of metastatic breast cancer (MBC)

✍ Scribed by Chan, S.; Davidson, N.; Juozaityte, E.; Erdkamp, F.; Hooftman, L.; Azarnia, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxotere® (T) and doxorubicin (D) combin

✍ Vallejos, C.; Nunez, P.; Orlandi, L.; Carranza, H.; Fodor, M.; Reyes, J.M.; Majl 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Liposome-encapsulated doxorubicin compar

✍ Lyndsay Harris; Gerald Batist; Robert Belt; Douglas Rovira; Rudolph Navari; Noza 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Gemcitabine, epirubicin and paclitaxel (

✍ T. Brodowicz; S. Beslija; J. Cervek; Z. Mrsic-Krmpotic; I. Tchernozemsky; C. Wil 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB